Playback speed
10 seconds
ESMO Breast 2024 Insights: "CAPItello-291 Trial PFS2 & TFSC Updates - Capivasertib & Fulvestrant for Patients With Aromatase Inhibitor-Resistant HR+/HER2- Advanced BC"
By
Insights from ESMO Breast 2024 Annual Meeting
FEATURING
Hope Rugo
By
Insights from ESMO Breast 2024 Annual Meeting
FEATURING
Hope Rugo
325 views
May 22, 2024
Login to view comments.
Click here to Login